Clinical Trials Arena September 25, 2025
Melissa Hall, legal director in MFMac’s Healthcare & Life Sciences team, reflects on what the UK Information Commissioner Office’s (ICO) new guidance around data could mean for clinical trials.
With the healthcare industry relying heavily on data for medical research and surveillance studies, it is critically important that sponsors, study sites and CROs know when data falls within the remit of ‘personal data’, which brings with it additional compliance requirements.
Earlier this year, we saw updated guidance from the UK Information Commissioner’s Office (ICO) on anonymisation and pseudonymisation which may impact how studies are approached. This new guidance matters because it doesn’t just clarify regulatory expectations – it exposes divergence between the UK and EU positions.
The European Data Protection...
Today's Sponsors
Today's Sponsor